Dr. Prakash Kolli, CEO and co-founder of 3D Orthobiologic Solutions (3DOS), is transforming the field of regenerative medicine through innovative 3D-printed bone graft scaffolds. The company’s mission is to simplify and enhance the healing, restoration, and regeneration of bone for patients suffering from defects caused by cancer, trauma, periodontal disease, or infection. 

The Personal and Technical Motivation 

The inception of 3DOS is deeply rooted in a personal experience. One of the company’s long-time advisors suffered jaw cancer and was ineligible for traditional bone grafts due to current medical limitations. Recognizing this unmet need, Dr. Kolli and his team combined their expertise to develop a groundbreaking solution that addresses this complex problem. 

Cutting-Edge Technology 

3DOS employs biofabrication, a form of 3D printing using natural biomaterials such as silk, collagen, and alginate, to create intricate bone graft scaffolds. This approach enables the body to integrate and regenerate tissue naturally, moving beyond traditional implants made of plastics and metals towards a more holistic healing process. 

Overcoming Challenges 

Navigating the complex regulatory landscape and scaling production remain significant hurdles. 3DOS collaborates closely with regulatory agencies and clinical experts to ensure safety and efficacy. Despite a competitive market, the company’s unique approach and strong intellectual property portfolio provide a competitive advantage. 

Expanding Applications and Partnerships 

Beyond oral surgery, 3DOS is exploring applications in orthopedic trauma, cranial, spinal, dental, maxillofacial, and veterinary medicine. The company actively seeks partnerships to broaden its reach and impact. 

The Role of MassChallenge 

MassChallenge has been instrumental in 3DOS’s growth, providing networking opportunities, mentorship, and resources crucial for commercialization and regulatory navigation. The supportive cohort community continues to offer valuable connections and collaborative opportunities. 

Looking Ahead 

With an FDA meeting scheduled and commercialization milestones on the horizon, 3DOS is poised to revolutionize bone regeneration and improve patients’ quality of life worldwide. 

3D Orthobiologic Solutions exemplifies mission-driven innovation at the intersection of technology and healthcare. Supported by MassChallenge’s empowering ecosystem, Dr. Prakash Kolli and his team are setting new standards in regenerative medicine.